The reduction of excitability of the gamma-loop by 1,3-dimethyl-5-aminoadamantane (DMAA).
D000547:Amantadine / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D002415:Cats; D003655:Decerebrate State; D003864:Depression, Chemical; D004558:Electric Stimulation; D005528:Foot; D006614:Hindlimb; D009046:Motor Neurons / Q000187:drug effects* / Q000502:physiology; D009119:Muscle Contraction / Q000187:drug effects; D009470:Muscle Spindles / Q000187:drug effects; D009132:Muscles / Q000294:innervation*; D009475:Neurons, Afferent / Q000502:physiology; D012026:Reflex, Stretch / Q000187:drug effects*
D000547:Amantadine